PAPER
N-Bromosuccinimide (NBS) Catalyzed Chemoselective Acetalization of Carbonyl Compounds
283
Chemicals were either prepared in our laboratories or purchased
from Merck, Fluka and Aldrich Chemical Companies. All yields re-
fer to isolated products unless otherwise stated. The products were
characterized by comparison of their physical data with those of
2-(4-Nitrophenyl)[1,3]dioxane (Table 1, Entry 8)
1H NMR (250 MHz, CDCl3, 25 °C, TMS): d = 7.98–8.28 (d, J = 9.0
Hz, 2 H), 7.62–7.73 (d, J = 9.0 Hz, 2 H), 5.54 (s, 1 H), 4.24–4.51
(dd, J = J = 5 Hz, 13.8 Hz, 2 H), 3.94–4.05 (pseudo-t, J = 13.8 Hz,
2 H), 2.13–2.25 (tq, J = 5 Hz, J = 13.3 Hz, 1 H), d = 1.43–1.50
(quintd, J = 1.1 Hz, J = 13.3 Hz, 1 H).
1
known samples or by their spectral data. H NMR and 13C NMR
spectra were recorded on Bruker 250 MHzor Bruker 500 MHz spec-
trometer in CDCl3 as the solvent and TMS as internal standard.
Most of the products are known. All of the isolated products gave
satisfactory IR and NMR spectra.
13C NMR (63 MHz, CDCl3, 25 °C, TMS): d = 154.5, 147.05,
132.33, 127.50, 102.52, 67.80, 34.5.
2-Methyl-2-phenyl[1,3]dioxane (Table 1, Entry 13)
1H NMR (250 MHz, CDCl3, 25 °C, TMS): d = 7.16–7.37 (m, 5 H),
3.66–3.78 (m, 4 H), 1.94–2.08 (tq, J = 5.4, 12.9 Hz 1 H), 1.44 (s, 3
H), 1.11–1.19 (quintd, J = 1.2, 12.9 Hz, 1 H).
13C NMR (63 MHz, CDCl3, 25 °C, TMS): d = 141.63, 129.10,
128.99, 128.24, 100.92, 61.62, 32.84, 25.89.
Synthesis of Acetals; General Procedure
To a solution of carbonyl compound (2 mmol), A, B, C (2.6–10
mmol), or D (1.2 mmol) in anhyd CH2Cl2 (10 mL), NBS (0.06–0.14
mmol) was added, and the resulting solution was stirred at r.t. After
completion of the reaction (TLC or GC), a cold aq solution of
NaOH (5%, 25 mL) was added and the mixture was extracted with
CH2Cl2 (3 × 15 mL). The organic extracts were washed successive-
ly with NaOH (5%, 15 mL), water (4 × 15 mL) and dried over anhyd
Na2SO4. Evaporation of the solvent under reduced pressure gave al-
most pure product(s). Further purification was carried out by vacu-
um distillation, re-crystallization in appropriate solvent or flash
chromatography using appropriate eluent to afford pure acetals
(Tables 1 and 2).
2-Methyl-2-(2-phenylethyl)[1,3]dioxane (Table 1, Entry 18)
1H NMR (250 MHz, CDCl3, 25 °C, TMS): d = 6.91–7.38 (m, 5 H),
3.79–3.89 (m, 4 H), 2.73–2.79 (m, 2 H), 1.98–2.05 (m, 2 H), 1.97–
1.73 (m, 1 H), 1.48–1.68 (m, 1 H), 1.44 (s, 3 H).
13C NMR (63 MHz, CDCl3, 25 °C, TMS): d = 139.01, 129.63,
129.65, 126.02, 100.85, 58.09, 41.50, 34.13, 23.67 18.27.
Acetalization of Highly Sensitive 3-(tert-Butyldimethylsilyl-
oxy)benzaldehyde; Typical Procedure
2-Furan-2-yl[1,3]dioxane (Table 1, Entry 24)
1H NMR (500 MHz, CDCl3, 25 °C, TMS): d = 7.37–7.38 (t, J = 0.86
Hz, 1 H), 6.41–6.42 (d, J = 3.2 Hz, 1 H), 6.34–6.35 (m, 1 H), 4.21–
4.24 (dd, J = 11.6, 5.0 Hz, 2 H), 3.91–3.97 (pseudo-t, J = 11.6 Hz,
2 H), 2.17–2.26 (tq, J = 5.0, 13.1 Hz, 1 H), 1.41–1.44 (quintd, J =
13.1, 1.9 Hz, 1 H).
To a solution of 3-(tert-butyldimethylsilyloxy)benzaldehyde (3
mmol, 710 mg), A (6 mmol, 1.32 g), in anhyd CH2Cl2 (15 mL),
NBS (0.12 mmol, 22 mg) was added, and the resulting solution was
stirred magnetically at r.t. After completion of the reaction (TLC),
a cold aq solution of NaOH (5%, 25 mL) was added and the mixture
was extracted with CH2Cl2 (3 × 25 mL). The organic extracts were
washed successively with NaOH (5%, 15 mL), water (4 × 20 mL)
and dried over anhyd Na2SO4. Evaporation of the solvent under re-
duced pressure gave almost pure product(s). Further purification of
the product was achieved using flash chromatography through a
short column of silica gel (2.5 cm × 5 cm) with n-hexane–EtOAc
(15:1) as eluent to afford the corresponding pure tert-butyl-(3-[1,3]-
dioxane-2-ylphenoxy)dimethylsilane as a bright yellow oil.
1H NMR (500 MHz, CDCl3, Me4Si): d = 7.22–7.25 (t, J = 7.9 Hz, 1
H), 7.02–7.11 (d, J = 7.9 Hz, 1 H), 7.01 (t, J = 2.0 Hz, 1 H), 6.82–
6.84 (dd, J = 7.9 Hz, J = 2.0 Hz, 2 H), 5.46 (s, 1 H), 4.24–4.28 (dd,
J = 11.0, 5.0 Hz, 2 H), 3.93–3.99 (pseudo-t, J = 11.0 Hz, 2 H), 2.17–
2.26 (tq, J = 5 Hz, 12.4 Hz), 1.39–1.44 (quintd, J = 2.4 Hz, J = 12.4
Hz, 1 H), 1.02 (s, 9 H), 0.23 (s, 6 H).
13C NMR (125 MHz, CDCl3, 25 °C, TMS): d = 156.20, 144.71,
109.52, 105.68, 102.55, 64.33, 26.29.
2-[4-Benzoyloxyphenyl][1,3]dioxane (Table 1, Entry 25)
1H NMR (500 MHz, CDCl3, 25 °C, TMS): d = 8.20–8.22 (dd, J =
8.4, 1.4 Hz, 2 H), 7.61–7.65 (tt, J = 7.4, 1.4 Hz, 1 H), 7.56–7.59 (d,
J = 8.4 Hz, 2 H), 7.49–7.53 (t, J = 7.4 Hz, 2 H), 7.23–7.26 (dd, J =
8.4 Hz, J = 1.4 Hz, 2 H), 5.54 (s, 1 H), 4.27–4.30 (dd, J = 11.0, 3.6
Hz, 2 H), 3.98–4.03 (pseudo-t, J = 11.0 Hz, 2 H), 2.20–2.27 (tq, J =
5.0, 13.3 Hz, 1 H), 1.44–1.48 (quintd, J = 1.3, 13.3 Hz, 1 H).
13C NMR (125 MHz, CDCl3, 25 °C, TMS): d = 165.08, 151.29,
136.58, 133.68, 130.25, 129.62, 128.65, 127.38, 121.55, 101.05,
67.45, 25.82.
2-[3-(Tetrahydropyran-2-yloxy)phenyl][1,3]dioxane (Table 1,
Entry 27)
13C NMR (125 MHz, CDCl3, 25 °C, TMS): d = 155.62, 140.40,
129.21, 120.22, 119.02, 117.94, 101.38, 67.35, 25.82, 25.76, 18.20,
–4.35.
1H NMR (500 MHz, CDCl3, 25 °C, TMS): d = 7.15–7.17 (t, J = 7.9
Hz, 1 H), 7.01–7.04 (d, J = 7.9 Hz, 1 H), 6.88–6.89 (t, J = 2.2 Hz, 1
H), 6.69–6.71 (dd, J = 7.9 Hz, J = 2.2 Hz, 1 H), 5.38 (s, 1 H), 4.52–
4.53 (m, 1 H), 4.15–4.18 (dd, J = 11.0 Hz, J = 5.0 Hz, 2 H), 4.00–
4.03 (m, 2 H), 3.86–3.91 (pseudo-t, J = 11.0 Hz, 2 H), 2.10–2.15 (tq,
J = 5.0 Hz, J = 12.7 Hz, 1 H), 1.96–2.02 (m, 1 H), 1.81–1.85 (m, 1
H), 1.47–1.50 (m, 3 H), 1.34–1.37 (m, 1 H), 1.23–1.27 (m, 1 H).
2-(4-Chlorophenyl)[1,3]dioxane (Table 1, Entry 4)
1H NMR (250 MHz, CDCl3, 25 °C, TMS): d = 7.40–7.49 (d, J = 8.0
Hz, 2 H), 7.30–7.34 (d, J = 8.0 Hz, 2 H), 5.44 (s, 1 H), 4.20–4.26
(dd, J = 5.0, 11.3 Hz, 2 H), 3.88–3.98 (pseudo-t, J = 11.3 Hz, 2 H),
2.14–2.23 (tq, J = 5 Hz, J = 13.2 Hz, 1 H), 1.37–1.43 (quintd, J =
1.2, 13.2 Hz, 1 H).
13C NMR (125 MHz, CDCl3, 25 °C, TMS): d = 156.58, 140.11,
129.28, 119.13, 117.50, 115.83, 102.29, 98.79, 67.27, 66.81, 30.68,
30.67, 25.44, 19.51.
13C NMR (63 MHz, CDCl3, 25 °C, TMS): d = 137.70, 134.95,
128.81, 127.91, 101.19, 67.78, 26.09.
2-Methyl-2-[3-(tetrahydropyran-2-yloxy)phenyl][1,3]dioxane
(Table 1, Entry 30)
2-(4-Bromophenyl)[1,3]dioxane (Table 1, Entry 5)
1H NMR (500 MHz, CDCl3, 25 °C, TMS): d = 7.49–7.51 (d, J = 8.5
Hz, 2 H), 7.35–7.38 (d, J = 8.5 Hz, 2 H), 5.46 (s, 1 H), 4.24–4.28
(dd, J = 4.9, 10.9 Hz, 2 H), 3.95–4.00 (pseudo-t, J = 10.9 Hz, 2 H),
2.16–2.26 (tq, J = 5.0 Hz, J = 13.3 Hz, 1 H), 1.43–1.47 (quintd, J =
1.3 Hz, J = 13.3 Hz, 1 H).
1H NMR (250 MHz, CDCl3, 25 °C, TMS): d = 7.30 (t, J = 7.60 Hz,
1 H), 7.15–6.95 (m, 3 H), 5.45 (t, J = 3.4 Hz, 1 H), 3.70–3.95 (m, 5
H), 3.60 (m, 1 H), 1.55–2.19 (m, 7 H), 1.47 (s, 3 H), 1.20 (quintd,
J = 1.1, 13.2 Hz, 1 H).
13C NMR (63 MHz, CDCl3, 25 °C, TMS): d = 157.6, 142.9, 129.8,
120.1, 114.9, 114.7, 100.2, 96.4, 61.9, 61.3, 31.9, 30.2, 25.4, 25.2,
18.7.
13C NMR (125 MHz, CDCl3, 25 °C, TMS): d = 138.60, 130.82,
129.60, 124.23, 101.67, 64.30, 24.21.
Synthesis 2005, No. 2, 279–285 © Thieme Stuttgart · New York